BLNAX
Price
$13.11
Change
+$0.08 (+0.61%)
Updated
Jul 9 closing price
Net Assets
417.1M
CRAZX
Price
$10.16
Change
+$0.05 (+0.49%)
Updated
Jul 9 closing price
Net Assets
2.43B
Interact to see
Advertisement

BLNAX vs CRAZX

Header iconBLNAX vs CRAZX Comparison
Open Charts BLNAX vs CRAZXBanner chart's image
Meeder Balanced Adviser
Price$13.11
Change+$0.08 (+0.61%)
VolumeN/A
Net Assets417.1M
Columbia Adaptive Risk Allocation Inst
Price$10.16
Change+$0.05 (+0.49%)
VolumeN/A
Net Assets2.43B
BLNAX vs CRAZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BLNAX vs. CRAZX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLNAX is a Buy and CRAZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CRAZX has more cash in the bank: 2.43B vs. BLNAX (417M). CRAZX pays higher dividends than BLNAX: CRAZX (2.37) vs BLNAX (1.55). BLNAX was incepted earlier than CRAZX: BLNAX (9 years) vs CRAZX (13 years). BLNAX (1.13) is less costly to investors than CRAZX (0.81). BLNAX is a more actively managed with annual turnover of: 247.00 vs. CRAZX (190.00). CRAZX has a lower initial minimum investment than BLNAX: CRAZX (2000) vs BLNAX (2500). CRAZX annual gain was more profitable for investors over the last year : 7.19 vs. BLNAX (-5.74). BLNAX return over 5 years is better than : 23.78 vs. CRAZX (11.20).
BLNAXCRAZXBLNAX / CRAZX
Total Expense Ratio1.130.81140%
Annual Report Gross Expense Ratio1.130.81140%
Fund Existence9 years13 years-
Gain YTD3.8986.08664%
Front LoadN/AN/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets417M2.43B17%
Annual Yield % from dividends1.552.3765%
Returns for 1 year-5.747.19-80%
Returns for 3 years16.0719.7681%
Returns for 5 years23.7811.20212%
Returns for 10 yearsN/A27.59-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PARWX55.55N/A
N/A
Parnassus Value Equity Investor
WILCX10.34N/A
N/A
Wasatch Global Value Institutional
CVMAX19.93N/A
N/A
Calvert Emerging Markets Equity A
MSVDX5.43N/A
N/A
Morgan Stanley Vitality Portfolio I
GEICX7.34N/A
N/A
Gabelli Equity Income C